The Preclinical Imaging Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the preclinical imaging market has significantly expanded in the past few years. It is expected to increase from $3.46 billion in 2024 to $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%.
The preclinical imaging market is anticipated to grow significantly in the coming years. By 2029, the market is projected to reach a value of $4.83 billion, with a compound annual growth rate (CAGR) of 6.9%.
Download Your Free Sample of the 2025 Preclinical Imaging Market Report and Uncover Key Trends Now!The key drivers in the preclinical imaging market are:
• Adoption of personalized medicine
• Advancements in molecular imaging technology
• The outsourcing of drug development processes
• Increased regulatory support for preclinical imaging
The preclinical imaging market covered in this report is segmented –
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User
The key trends in the preclinical imaging market are:
• The trend of adopting green imaging technologies is significantly shaping the future of the preclinical imaging market.
• There is an ongoing influence of technological advancements in this field.
• Increased R&D activities are emerging as a trending driver in the market.
• The future of the market is seeing an increased trend in collaborations, partnerships, and real-time imaging.
The major players in the preclinical imaging market are:
• Thermo Fisher Scientific Inc
North America was the largest region in the preclinical imaging market in 2024